Registration number: 1100154
Cure Leukaemia is making significant strides in the fight against leukemia, offering potential life-saving treatment to patients across the UK. Their commitment to expanding access to treatment is evident in their expansion from 12 to 15 centers nationwide, ensuring that more individuals have access to cutting-edge therapies and support. By scaling up their efforts to a national level, Cure Leukaemia is advancing the fight against leukemia and providing hope to countless patients and their families.
From the founding year and expanding team to generous donations and growing turnover, these key figures highlight the scale and impact of Cure Leukaemia’s work over the last year.
Cure Leukaemia, founded in 2003 by Professor Charlie Craddock CBE and patients Graham Silk and Michael Woolley, is a national blood cancer charity dedicated to advancing access to lifesaving treatments through clinical trials. The charity funds the Trials Acceleration Programme (TAP), a nationwide network of specialist research nurses in 15 UK cities, enabling the rapid delivery of blood cancer trials and offering patients access to groundbreaking treatments not available through standard care. In 2024, Cure Leukaemia launched the ATICUS Network, bringing together 11 leading children’s hospitals to improve outcomes for pediatric stem cell transplants. The charity’s vital work is powered by fundraising initiatives, donations, and corporate partnerships, providing opportunities for individuals and businesses to contribute to the fight against blood cancer.
Find out moreWhether you are a donor, charity or organisation, staying informed helps you make impactful choices. Sign up for our newsletter to keep up to date with the charity space.